SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Jan-24 4:44 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Jan-24 | Payment of Exercise | 9,125 | $1.05 | $9,581.25 | (18%) 50.94K to 41.81K | |
03-Jan-24 4:44 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Jan-24 | Option Exercise | 27,000 | -- | -- | 113% 23.94K to 50.94K | |
03-Aug-23 4:24 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Aug-23 | Payment of Exercise | 4,437 | $9.81 | $43,527.00 | (16%) 28.38K to 23.94K | |
03-Aug-23 4:24 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Aug-23 | Option Exercise | 15,575 | -- | -- | 122% 12.8K to 28.38K | |
17-Mar-23 5:03 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 17-Mar-23 | Private Purchase | 6,300 | $7.86 | $49,532.50 | 97% 6.5K to 12.8K | |
09-Mar-23 5:56 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 09-Mar-23 | Private Purchase | 6,500 | $7.74 | $50,277.50 | 100% 0 to 6.5K | |
11-Mar-22 4:12 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 36,462 | -- | -- | (100%) 36.46K to 0 | |
05-Jan-22 5:02 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 03-Jan-22 | Grant | 21,462 | -- | -- | 143% 15.0K to 36.46K | |
17-Aug-21 8:30 AM View: | Arena Pharmaceuticals, Inc. (ARNA) | 15-Aug-21 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K |